Basit öğe kaydını göster

dc.contributor.authorYadigar, Serap
dc.contributor.authorRonco, Claudio
dc.contributor.authorDİNCER, Mevlüt Tamer
dc.contributor.authorMURT, Ahmet
dc.contributor.authorParmaksiz, Ergun
dc.contributor.authorYalin, Serkan Feyyaz
dc.contributor.authorALTIPARMAK, Mehmet Rıza
dc.date.accessioned2021-03-02T15:44:37Z
dc.date.available2021-03-02T15:44:37Z
dc.identifier.citationYalin S. F. , ALTIPARMAK M. R. , DİNCER M. T. , Yadigar S., MURT A., Parmaksiz E., Ronco C., "Medium Cut-Off Dialysis Membranes: Can They Have Impact on Outcome of COVID-19 Hemodialysis Patients?", BLOOD PURIFICATION, 2021
dc.identifier.issn0253-5068
dc.identifier.othervv_1032021
dc.identifier.otherav_879a3d35-2c83-4756-b8f9-8e93b5af5820
dc.identifier.urihttp://hdl.handle.net/20.500.12627/1632
dc.identifier.urihttps://doi.org/10.1159/000513621
dc.description.abstractIntroduction: Severe acute respiratory syndrome coronavirus-2 may lead to high levels of expression of inflammatory cytokines. Medium cut-off (MCO) membranes may make greater clearances for large-middle molecules (including cytokines) than low-flux (LF) membranes. In this study, we aimed to evaluate the impact of MCO membranes on outcome of COVID-19 patients on hemodialysis (HD). Methods: Sixty COVID-19 HD patients were included in this study. The patients were categorized into 2 groups regarding type of HD membranes. Clinical data were taken from medical records. Results: Initial crp and ferritin levels, which are surragates of cytokine storm and severity of disease in COVID-19, were significantly higher in MCO membrane group compared to LF group (p = 0.037 and 0.000, respectively). Although there were more patients with severe disease in MCO group, there were no significant differences regarding need for intensive care unit and death. Conclusion: It may be an option to use MCO membranes in HD patients with COVID-19 in order to reduce cytokine levels and prevent cytokine storm.
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.subjectNefroloji
dc.subjectNephrology
dc.subjectUrology
dc.subjectHematology
dc.subjectHealth Sciences
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectHEMATOLOJİ
dc.titleMedium Cut-Off Dialysis Membranes: Can They Have Impact on Outcome of COVID-19 Hemodialysis Patients?
dc.typeMakale
dc.relation.journalBLOOD PURIFICATION
dc.contributor.departmentKartal Dr Lutfi Kirdar City Hosp , ,
dc.contributor.firstauthorID2513571


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster